Total Payments
$14,615
2024 Payments
$1,905
Companies
33
Transactions
156
Medicare Patients
3,130
Medicare Billing
$377,534
Payment Breakdown by Category
Other$9,740 (66.6%)
Food & Beverage$3,315 (22.7%)
Travel$1,036 (7.1%)
Consulting$525.00 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,740 | 2 | 66.6% |
| Food and Beverage | $3,315 | 143 | 22.7% |
| Travel and Lodging | $1,036 | 10 | 7.1% |
| Consulting Fee | $525.00 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medline Industries, Inc. | $9,740 | 2 | $0 (2021) |
| Medtronic, Inc. | $1,356 | 18 | $0 (2024) |
| ABBVIE INC. | $694.22 | 39 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $525.00 | 1 | $0 (2020) |
| PFIZER INC. | $382.90 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $355.01 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $172.43 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $150.88 | 2 | $0 (2023) |
| GENZYME CORPORATION | $149.07 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $128.26 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,905 | 57 | Medtronic, Inc. ($846.78) |
| 2023 | $1,118 | 35 | Medtronic, Inc. ($495.23) |
| 2022 | $439.60 | 12 | Regeneron Healthcare Solutions, Inc. ($124.99) |
| 2021 | $7,916 | 8 | Medline Industries, Inc. ($7,740) |
| 2020 | $2,525 | 2 | Medline Industries, Inc. ($2,000) |
| 2019 | $187.58 | 9 | Janssen Biotech, Inc. ($69.60) |
| 2018 | $191.47 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($64.49) |
| 2017 | $333.19 | 22 | AbbVie, Inc. ($112.36) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.27 | General |
| 12/16/2024 | STERIS CORPORATION | truFreeze (Device) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.99 | General |
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/19/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $35.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.67 | General |
| 10/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 611 | 676 | $822,920 | $81,010 |
| 2022 | 14 | 672 | 732 | $475,802 | $88,228 |
| 2021 | 16 | 949 | 1,030 | $715,750 | $113,644 |
| 2020 | 15 | 898 | 1,013 | $605,529 | $94,651 |
Total Patients
3,130
Total Services
3,451
Medicare Billing
$377,534
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 199 | $86,012 | $19,783 | 23.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 101 | 102 | $268,869 | $19,070 | 7.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 65 | $44,864 | $8,754 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $40,243 | $8,207 | 20.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 55 | 56 | $128,215 | $6,009 | 4.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 66 | 68 | $135,098 | $5,531 | 4.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 38 | $13,401 | $3,576 | 26.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $33,237 | $3,480 | 10.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $28,308 | $2,766 | 9.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $37,295 | $2,220 | 6.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $7,379 | $1,614 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 130 | 130 | $150,686 | $23,245 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 135 | $41,524 | $13,620 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 74 | 77 | $34,152 | $11,980 | 35.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 78 | 81 | $74,686 | $7,617 | 10.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 37 | 37 | $32,125 | $7,059 | 22.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 53 | $12,296 | $4,404 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $12,495 | $4,281 | 34.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 47 | 48 | $55,657 | $4,051 | 7.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $11,720 | $2,774 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 44 | $10,160 | $2,660 | 26.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $16,899 | $1,988 | 11.8% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $5,890 | $1,966 | 33.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $12,264 | $1,854 | 15.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 27 | 27 | $5,249 | $727.52 | 13.9% |
About Dr. Richard Tilson, MD
Dr. Richard Tilson, MD is a Gastroenterology healthcare provider based in Lowell, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346336831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Tilson, MD has received a total of $14,615 in payments from pharmaceutical and medical device companies, with $1,905 received in 2024. These payments were reported across 156 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,740).
As a Medicare-enrolled provider, Tilson has provided services to 3,130 Medicare beneficiaries, totaling 3,451 services with total Medicare billing of $377,534. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lowell, MA
- Active Since 10/04/2006
- Last Updated 01/20/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346336831
Products in Payments
- Dermatology and Wound Care (Medical Supply) $9,740
- INTERSTIM (Device) $1,342
- STELARA (Biological) $697.43
- XELJANZ (Drug) $364.59
- DUPIXENT (Biological) $299.95
- SKYRIZI (Biological) $203.74
- Humira (Biological) $146.04
- IBSRELA (Drug) $111.78
- XIFAXAN (Drug) $104.31
- Vemlidy (Drug) $101.60
- RINVOQ (Biological) $100.25
- GATTEX (Drug) $72.31
- MAVYRET (Drug) $61.75
- CREON (Drug) $59.95
- ENTYVIO (Biological) $58.47
- ZEPOSIA (Drug) $55.22
- Epclusa (Drug) $53.34
- GIVLAARI (Drug) $48.88
- OCALIVA (Drug) $46.49
- MOVIPREP (Drug) $42.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lowell
Supriya Rao, M.d, M.D
Gastroenterology — Payments: $18,980
Gastroenterology $18,980
Mr. Terryl Ortego, M.d, M.D
Gastroenterology — Payments: $8,293
Gastroenterology $8,293
Franklin Marinelli, Md, MD
Gastroenterology — Payments: $3,190
Gastroenterology $3,190
Mr. Stephen Stagg, M.d, M.D
Gastroenterology — Payments: $2,108
Gastroenterology $2,108